GlassScriptPhysician profile
Michael A Krafchick
NPI 1275623506
$12,575.67
in general payments reported to CMS, 2019-2025
66 companies · $1,244 in 2025
The $1,244 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,213 · 2020: $1,358 · 2021: $1,065 · 2022: $766 · 2023: $2,478 · 2024: $3,453 · 2025: $1,244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,174.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,784.77 | 2019-2025 | |
| Novo Nordisk INC | $1,226.65 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $1,226.27 | 2019-2025 | |
| Glaxosmithkline, LLC. | $800.22 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $790.29 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Corium, LLC | $632.84 | 2022-2025 | Azstarys |
| Lilly USA, LLC | $546.20 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $538.12 | 2019-2024 | Jardiance, Synjardy |
| Axsome Therapeutics, INC. | $339.95 | 2024-2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $315.22 | 2019-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $274.92 | 2022-2025 | Xifaxan |
| Teva Pharmaceuticals USA, INC. | $250.82 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Allergan, INC. | $247.52 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $238.67 | 2019-2021 | |
| Gilead Sciences, INC. | $223.74 | 2019-2020 |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $223.17 | 2020-2025 | Vivitrol, Vivitrol |
| Phathom Pharmaceuticals, INC. | $203.95 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $201.40 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Supernus Pharmaceuticals, INC. | $184.45 | 2022-2023 | Qelbree |
| Daiichi Sankyo INC. | $173.93 | 2019-2025 | Injectafer |
| Astellas Pharma US INC | $137.83 | 2024-2025 | Veozah |
| Tris Pharma INC | $116.17 | 2023-2024 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $111.21 | 2019-2020 | |
| Amgen INC. | $109.84 | 2019-2024 | Otezla, Repatha |
| Indivior INC. | $101.37 | 2019-2025 | Sublocade |
| Almatica Pharma LLC | $100.24 | 2023-2025 | Loreev Xr, Gralise |
| Abbott Laboratories | $99.67 | 2023-2025 | Freestyle Libre 3, Proclaim, Freestyle Libre 2 |
| Ironshore Pharmaceuticals INC. | $83.23 | 2019 | |
| Hikma Pharmaceuticals USA | $70.98 | 2019-2020 | |
| Amarin Pharma, INC. | $69.73 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $68.95 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $62.02 | 2024-2025 | Eliquis |
| Tolmar, INC. | $58.46 | 2023-2024 | |
| Adlon Therapeutics L.P. | $57.67 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $54.98 | 2024-2025 | Caplyta |
| Xeris Pharmaceuticals, INC. | $53.06 | 2023-2024 | Gvoke Hypopen |
| Eisai INC. | $49.50 | 2024 | |
| Genentech USA, INC. | $48.41 | 2019-2020 | |
| Inspire Medical Systems, INC. | $42.43 | 2024 | Inspire |
| Jazz Pharmaceuticals INC. | $40.90 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $38.43 | 2024-2025 | |
| Madrigal Pharmaceuticals | $37.96 | 2024 | Resmetirom |
| Horizon Therapeutics Plc | $37.69 | 2019 | |
| Shield Therapeutics INC | $37.51 | 2024 | |
| Hologic Sales and Service, LLC | $36.19 | 2020-2023 | Thinprep 2000 Processor, Aptima |
| Orexo US, INC. | $33.67 | 2019-2021 | |
| Idorsia Pharmaceuticals US INC | $31.40 | 2023 | Quviviq |
| Verity Pharmaceuticals INC. | $29.55 | 2024 | Tlando |
| Kyowa Kirin, INC. | $29.28 | 2024 | Crysvita |
| Zyla Life Sciences, INC. | $24.52 | 2019-2020 | |
| Pacira Therapeutics, INC. | $21.15 | 2021 | |
| Alexion Pharmaceuticals, INC. | $20.49 | 2021 | |
| Aytu Biopharma, INC. | $20.09 | 2020 | |
| Antares Pharma, INC. | $19.95 | 2019 | |
| Intra-Sana Laboratories | $18.83 | 2025 | Glycate, Reltone 400 Mg, Reltone 200 Mg |
| Neos Therapeutics, LP | $18.61 | 2022 | |
| Nestle Healthcare Nutrition INC. | $18.31 | 2021 | |
| Eyevance Pharmaceuticals LLC | $18.21 | 2021 | |
| Philips North America LLC | $18.20 | 2020 | |
| Ardelyx, INC. | $16.81 | 2023 | Ibsrela |
| Braeburn INC. | $16.11 | 2024 | Brixadi |
| Biohaven Pharmaceuticals, INC. | $15.13 | 2021 | |
| Medline Industries LP | $14.84 | 2024 | Medline Industries, INC. |
| Sanofi Pasteur INC. | $14.68 | 2022 | |
| Oxford Immunotec USA INC | $14.38 | 2020 | |
| Currax Pharmaceuticals LLC | $13.93 | 2023 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Krafchick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.